Krónikus mieloid leukémia (CML): vizsgálatok itt: Kína
21 trials · From ClinicalTrials.gov, checked 2026. november 12.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleStudy to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
- Where
- Tianjin, Zhengzhou
- Életkor
- 1 év to 18 év
- People
- 50 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07354074 - 4. fázisTaking peopleAsciminib Roll-over Study
- Where
- Beijing, Changchun, Chengdu, Chongqing, Guangzhou, Shanghai, Shenyang, Tianjin, Wuhan, Xian, Zhengzhou
- Életkor
- 7 év to 100 év
- People
- 347 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04877522 · EU 2023-507557-16-00 - 1. fázisTaking peoplePhase 1 Study of 6MW5311 in Adults With Relapsed or Refractory Blood Cancers
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 122
- Run by
- Mabwell (Shanghai) Bioscience Co., Ltd.
See details and how to joinNCT07914556 - 3. fázisNot yet taking people in KínaA Study of HS-10382 Versus Investigator-selected TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CP
- Where
- Wuhan
- Életkor
- 18 év and over
- People
- 408
- Run by
- Jiangsu Hansoh Pharmaceutical Co., Ltd.
See details and how to joinNCT07885293 - 4. fázisNot yet taking people in KínaDe-escalation Strategy of Tyrosine Kinase Inhibitors Before Treatment Discontinuation in Patients With Chronic Myeloid Leukemia
- Where
- Guangzhou
- Életkor
- 18 év to 80 év
- People
- 280
- Run by
- Nanfang Hospital, Southern Medical University
See details and how to joinNCT07839988 - No phaseTaking peopleThiotepa-Containing Conditioning Regimen for Allogeneic HSCT in Chronic Myelomonocytic Leukemia
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 31
- Run by
- Peking University People's Hospital
See details and how to joinNCT07588594 - 1. fázisTaking peopleA Study to Assess Safety and Preliminary Efficacy of LP-108 Combined With Azacitidine In Subjects With AML, MDS, CMML
- Where
- Nanchang, Suzhou, Zhengzhou
- Életkor
- 18 év and over
- People
- 198
- Run by
- Guangzhou Lupeng Pharmaceutical Company LTD.
See details and how to joinNCT05641259 - 1/2. fázisTaking peopleStudy of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
- Where
- Baoding, Bengbu, Chongqing, Guangzhou, Hangzhou, Hefei, Linyi, Nanchang, Shenyang, Suzhou, Tianjin, Zhengzhou
- Életkor
- 12 év and over
- People
- 160 worldwide
- Run by
- Sellas Life Sciences Group
See details and how to joinNCT04588922 - No phaseTaking peopleLow-dose Liposomal Amphotericin B for Antifungal Prophylaxis in Prolonged Neutropenia Patients
- Where
- Hainan
- Életkor
- 18 év to 75 év
- People
- 30
- Run by
- Haikou Affiliated Hospital of Central South University Xiangya School of Medicine
See details and how to joinNCT07763054 - No phaseTaking peopleReal-world Study of Scemblix in the Treatment of Chronic Myeloid Leukemia in China
- Where
- Wuhan
- Életkor
- 18 év to 99 év
- People
- 200
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07375355 - No phaseCsak meghívásosObservational Study on Dose Optimization of Olverembatinib in Patients With Chronic Myeloid Leukemia in Chronic or Accelerated Phase
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 100
- Run by
- Qian Jiang
See details and how to joinNCT07383298 - 3. fázisTaking peopleIMM01+Azacitidine VS Placebo +Azacitidine in Patients With Newly Diagnosed Chronic Myelomonocytic Leukemia (CMML1-2)
- Where
- Beijing, Changchun, Changsha, Changzhou, Chengdu, Chongqing, Guangzhou, Guiyang, Hangzhou, Harbin, Hefei, Jinan, Kunming, Lanzhou, Nanchang, Nanjing, Nanning, Ningbo, Shenyang, Shenzhen, Shijiazhuang, Suzhou, Tianjin, Ürümqi, Wenzhou, Wuhan, Xi'an, Xiangyang, Xuzhou, Yangzhou, Yibin, Zhengzhou, Zhujiang
- Életkor
- 18 év and over
- People
- 170
- Run by
- ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
See details and how to joinNCT06647862 - No phaseTaking peopleThe Efficacy and Safety of Third-generation TKIs Combined With Azacitidine and Bcl-2 Inhibitor in Patients With CML-MBP
- Where
- Beijing, Chengdu, Guangdong, Kunming, Nanjing, Nanning, Nanyang, Ningbo, Qilu, Tianjin, Wuhan, Xi'an, Zhejiang
- Életkor
- 18 év and over
- People
- 30
- Run by
- Peking University People's Hospital
See details and how to joinNCT06390306 - 1/2. fázisTaking peopleOlverembatinib Combined With Venetoclax and Azacitidine in Blast Phase Ph Chromosome-positive CML
- Where
- Tianjin
- Életkor
- 15 év and over
- People
- 29
- Run by
- Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT06757855 - 2. fázisNot yet taking people in KínaSelinexor Combined With Azacitidine Therapy in High-Risk Myeloid Neoplasms Patients
- Where
- Tianjin
- Életkor
- 16 év to 75 év
- People
- 20
- Run by
- Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT06900088 - 2. fázisTaking peopleTGRX-678 Chinese Phase II in Chronic Myelogenous Leukemia (CML) Patients
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 40
- Run by
- Shenzhen TargetRx Co., Ltd.
See details and how to joinNCT06453902 - 1. fázisNot yet taking people in KínaA Clinical Trial to Evaluate the Safety and Tolerability of TQB3911 Tablets in Patients With BCR::ABL Fusion Gene Positive Leukemia
- Where
- Beijing, Hangzhou, Nanning, Shanghai, Zhengzhou
- Életkor
- 18 év and over
- People
- 120
- Run by
- Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
See details and how to joinNCT06672263 - No phaseTaking peopleIntensive Conditioning withTHI/Bu/Flu/Ara-C in Allo-HSCT for Myeloid Malignancies With Extramedullary Involvement
- Where
- Shanghai
- Életkor
- 18 év to 55 év
- People
- 50
- Run by
- Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT06111612 - No phaseTaking peopleInternational Chronic Myeloid Leukemia Pediatric Study
- Where
- Hong Kong
- Életkor
- Up to 18 év
- People
- 750 worldwide
- Run by
- Poitiers University Hospital
See details and how to joinNCT01281735 - 1/2. fázisTaking peopleUnrelated Umbilical Cord Blood Stem Cell Combined With Azacitidine Based Treatment for Advanced MDS,CMML-2 and sAML
- Where
- Nanjing
- Életkor
- 18 év to 80 év
- People
- 50
- Run by
- The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT05584761 - 4. fázisNot yet taking people in KínaA Real World Study of the Efficacy and Safety of Flumatinib Versus Imatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase
- Where
- Harbin
- Életkor
- 18 év and over
- People
- 2400
- Run by
- Jiangsu Hansoh Pharmaceutical Co., Ltd.
See details and how to joinNCT05367765